Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.95
+0.18100.52%
Volume:6K
Turnover:223.97K
Market Cap:44.56M
PE:- -
High:35.10
Open:35.10
Low:34.85
Close:34.77
52wk High:35.61
52wk Low:27.36
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.71
T/O Rate:0.50%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

Ascendis Pharma A/S Expected to Post Earnings of €1.38 a Share - Earnings Preview

Reuters
·
Aug 11

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Reuters
·
Aug 11

UK MHRA Expands Rhythm’s Imcivree Authorization to Treat Acquired Hypothalamic Obesity

Reuters
·
Aug 11

Rhythm Pharmaceuticals: to Work Closely with UK's Nhs to Finalize Guidance for Coverage of Imcivree for Acquired Ho

THOMSON REUTERS
·
Aug 11

Rhythm Pharmaceuticals Announces Imcivree® (Setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity Due to Hypothalamic Injury or Impairment

THOMSON REUTERS
·
Aug 11

Legend Biotech Rises After Second Quarter Results Beat Estimates

Reuters
·
Aug 11

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Reuters
·
Aug 11

Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 Adjusted EPS USD 0.16 VS. Ibes Estimate USD 0.07

THOMSON REUTERS
·
Aug 11

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

THOMSON REUTERS
·
Aug 11

After Multiple Bearish Catalysts, Legend Biotech's Stock Halved in Two Months: Value Trap or Bargain Opportunity?

Stock News
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

Lakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook

TIPRANKS
·
Aug 11